Crohn's disease trials in Hong Kong

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  Where

  Hksar

  Age

  16 years to 80 years

  People

  1,200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06430801 · EU 2023-508636-61-00
• No phaseNot yet taking people in Hong Kong
  A Pilot Study: Micro and NanoPlastics in Association With Crohn's Disease

  Where

  Hong Kong

  Age

  18 years to 80 years

  People

  90

  Run by

  Mak Wing Yan

  See details and how to joinNCT07630883
• No phaseTaking people
  Safety and Efficacy of Fecal Microbiota Transplantation

  Where

  Hong Kong

  People

  450

  Run by

  Chinese University of Hong Kong

  See details and how to joinNCT04014413
• No phaseTaking people
  GWA Study in Patients With Inflammatory Bowel Disease

  Where

  Hong Kong

  Age

  18 years and over

  People

  3,600

  Run by

  Chinese University of Hong Kong

  See details and how to joinNCT01140789